<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35874958</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1449-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>12</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>International journal of biological sciences</Title><ISOAbbreviation>Int J Biol Sci</ISOAbbreviation></Journal><ArticleTitle>Long COVID and its Management.</ArticleTitle><Pagination><StartPage>4768</StartPage><EndPage>4780</EndPage><MedlinePgn>4768-4780</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/ijbs.75056</ELocationID><Abstract><AbstractText>The pandemic of COVID-19 is the biggest public health crisis in 21<sup>st</sup> Century. Besides the acute symptoms after infection, patients and society are also being challenged by the long-term health complications associated with COVID-19, commonly known as long COVID. While health professionals work hard to find proper treatments, large amount of knowledge has been accumulated in recent years. In order to deal with long COVID efficiently, it is important for people to keep up with current progresses and take proactive actions on long COVID. For this purpose, this review will first introduce the general background of long COVID, and then discuss its risk factors, diagnostic indicators and management strategies. This review will serve as a useful resource for people to understand and prepare for long COVID that will be with us in the foreseeable future.</AbstractText><CopyrightInformation>&#xa9; The author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koc</LastName><ForeName>Ho Cheng</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Centre of Reproduction, Development &amp; Aging, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre of Reproduction, Development &amp; Aging, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interventional Medical Centre, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai 519000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Centre of Reproduction, Development &amp; Aging, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioimaging and Stem Cell Core Facility, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Interventional Medical Centre, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai 519000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Guokai</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Centre of Reproduction, Development &amp; Aging, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Int J Biol Sci</MedlineTA><NlmUniqueID>101235568</NlmUniqueID><ISSNLinking>1449-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">drug repurposing</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">management</Keyword><Keyword MajorTopicYN="N">post-acute COVID syndrome (PACS)</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 (PASC)</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>25</Day><Hour>4</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35874958</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pii">ijbsv18p4768</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Ag. 2020. 55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review. Jama-J Am Med Assoc. 2020;324:782&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (vol 395, pg 1054, 2020) Lancet. 2020;395:1038. -</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO COVID-19 Dashboard. Geneva: World Health Organization. 2020.</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review. medRxiv. 2021. 2021. 11.15.21266377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs A, Vassall A. Count the cost of disability caused by COVID-19. Nature. 2021;593:502&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34040204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM, Summers LH. The COVID-19 Pandemic and the $16 Trillion Virus. JAMA. 2020;324:1495&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271. -+</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sender R, Bar-On YM, Gleizer S, Bernshtein B, Flamholz A, Phillips R. et al. The total number and mass of SARS-CoV-2 virions. Proceedings of the National Academy of Sciences. 2021;118:e2024815118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237675</ArticleId><ArticleId IdType="pubmed">34083352</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JZ, Gong XB, Wang ZG, Chen RZ, Li TY, Zeng DY, Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China. Virus Res. 2020. 286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265838</ArticleId><ArticleId IdType="pubmed">32502551</ArticleId></ArticleIdList></Reference><Reference><Citation>Oran DP, Topol EJ. The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review. Ann Intern Med. 2021;174:655&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7839426</ArticleId><ArticleId IdType="pubmed">33481642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72&#x202f;314 Cases From the Chinese Center for Disease Control and Prevention. Jama. 2020;323:1239&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clinical immunology. 2020;215:108427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169933</ArticleId><ArticleId IdType="pubmed">32325252</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C- A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. Manchester: National Institute for Health and Care Excellence. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;95.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC. et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. Mmwr-Morbid Mortal W. 2020;69:993&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Aute GAC-P. Persistent Symptoms in Patients After Acute COVID-19. Jama-J Am Med Assoc. 2020;324:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021. 38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76:405&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, Mehrabadi MA, Abrihim H, Dutt N, COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC. et al. Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekanecz Z, Valyi-Nagy I. Post-acute COVID-19 syndrome. Orv Hetil. 2021;162:1067&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">34224394</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei M, Bose D, Nouri-Vaskeh M, Tajiknia V, Zand R, Ghasemi M. Long-term side effects and lingering symptoms post COVID-19 recovery. Rev Med Virol. 2021: e2289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646420</ArticleId><ArticleId IdType="pubmed">34499784</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>ONS. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. In: Statistic OfN, editor. Newport. 2022.</Citation></Reference><Reference><Citation>Mo X, Jian W, Su Z, Chen M, Peng H, Peng P. et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal. 2020;55:2001217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS. et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021;18:508&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D. et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11:e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R. et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clinical Medicine. 2021;21:e63&#x2013;e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL. et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021;10:386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. The Lancet Psychiatry. 2021;8:416&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M. et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144:1263&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Manca R, De Marco M, Ince PG, Venneri A. Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories. Front Aging Neurosci. 2021;13:646908. -</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209297</ArticleId><ArticleId IdType="pubmed">34149394</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, SARS-CoV-2 is associated with changes in brain structure in UK Biobank. medRxiv. 2022. 2021. 06.11.21258690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397:220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R. et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma &amp; Clinical Immunology. 2013;9:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3765115</ArticleId><ArticleId IdType="pubmed">23947590</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRdB. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Frontiers in Immunology. 2021. 12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Beumer J, Van Der Vaart J, Knoops K, Puschhof J, Breugem TI. et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD. et al. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut. 2016;65:575&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4819612</ArticleId><ArticleId IdType="pubmed">26511795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Zhou H, Wu W-K, Fu T, Yan M, He Z, Alterations in the Composition of Intestinal DNA Virome in Patients With COVID-19. Frontiers in Cellular and Infection Microbiology. 2021. 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653907</ArticleId><ArticleId IdType="pubmed">34900762</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, Yeoh YK, Lui GC-Y, Ng SSS. et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544.</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestad B, Ueland T, Lerum TrV, Dahl TBr, Holm K, Barratt-Due A, Gut microbiota alterations in patients with persistent respiratory dysfunction three months after severe COVID-19. medRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115297</ArticleId><ArticleId IdType="pubmed">35212063</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek M, Rayner C, Freyer A, Taylor S, J&#xe4;rte L, MacDermott N. et al. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. British Journal of General Practice. 2021;71:e815&#x2013;e25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR. LIVING WITH COVID19. London Natioanl Institute for Health Research. 2021.</Citation></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021;112:217&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2022;70:61&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto MD, Lambert N, Downs CA, Abrahim H, Hughes TD, Rahmani AM. et al. Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J Nurse Pract. 2022;18:335&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureen Z, Dautaj A, Nodari S, Fioretti F, Dhuli K, Anpilogov K. et al. Proposal of a food supplement for the management of post-COVID syndrome. Eur Rev Med Pharmacol Sci. 2021;25:67&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">34890036</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossato MS, Brilli E, Ferri N, Giordano G, Tarantino G. Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS-CoV-2 post-infection progress. Clinical Nutrition ESPEN. 2021;46:510&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420132</ArticleId><ArticleId IdType="pubmed">34857243</ArticleId></ArticleIdList></Reference><Reference><Citation>Memme JM, Erlich AT, Phukan G, Hood DA. Exercise and mitochondrial health. The Journal of Physiology. 2021;599:803&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31674658</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 'long-haulers'? Chronic Dis Transl Med. 2021;7:14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagenlocher Y, Lorentz A. Immunomodulation of mast cells by nutrients. Molecular Immunology. 2015;63:25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">24524883</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022. 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF. et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao B, Liu Z, Tang L, Li L, Gan Q, Shi H. et al. Longitudinal clinical and radiographic evaluation reveals interleukin-6 as an indicator of persistent pulmonary injury in COVID-19. Int J Med Sci. 2021;18:29&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738960</ArticleId><ArticleId IdType="pubmed">33390771</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvisi M, Ferrozzi F, Balzarini L, Mancini C, Ramponi S, Uccelli M. First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution. Int J Infect Dis. 2020;99:485&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443096</ArticleId><ArticleId IdType="pubmed">32841688</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F. et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N. et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) Journal of Translational Medicine. 2022;20:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. Plos One. 2020. 15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J. et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infection. 2021;82:378&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke LM, Glockner S, Dreier M, Lange B. Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review. J Infect. 2021;82:1&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9183207</ArticleId><ArticleId IdType="pubmed">33278399</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health. 2021. 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science (New York, NY) 2020;369:718&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Attributes and predictors of long COVID. Nat Med. 2021. 27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Hand Timothy W. Role of the Microbiota in Immunity and Inflammation. Cell. 2014;157:121&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y. et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26:502&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095102</ArticleId><ArticleId IdType="pubmed">32284613</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsi Y, Tahvildari A, Arbabi M, Vazife F, Sechi L, Hashem A, Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review. Frontiers in Cellular and Infection Microbiology. 2022. 12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8930898</ArticleId><ArticleId IdType="pubmed">35310853</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H. et al. Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19) Clin Infect Dis. 2021;73:E1089&#x2013;E98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Schiabor Barrett KM, Riffle S, Bolze A, Neveux I, Dabe S, Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020. 2020. 10.07.20208702.</Citation></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93:1013&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Carinena A, Moreno E, Rodriguez N, Dominguez MJ, Casal A. et al. Post-COVID-19 functional status six-months after hospitalization. J Infection. 2021;82:E31&#x2013;E3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>WorldHealthOrganization. Tracking SARS-CoV-2 variants. 2022.</Citation></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. The Lancet. 2022;399:2263&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK. medRxiv. 2021. 2021. 06.24.21259277.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyraz BC, Poyraz CA, Olgun Y, Gurel O, Alkan S, Ozdemir YE. et al. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. 2021;295:113604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7695976</ArticleId><ArticleId IdType="pubmed">33296818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, E B. et al. Long COVID occurrence in COVID-19 survivors. Sci Rep-Uk. 2022;12:6039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk - a signal to address sex hormones and women's health. The Lancet Regional Health - Europe. 2021. 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health-Eu. 2021. 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, Sagharichi M, Aalipour MA, Ghorbani F. et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27:154&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2021: S1198-743X(21)00629-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurmanova AM, Kurmanova GM, Lokshin VN. Reproductive dysfunctions in viral hepatitis. Gynecol Endocrinol. 2016;32:37&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">27759450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Jabal KA, Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. medRxiv. 2022. 2022. 01.05.22268800.</Citation></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. The Lancet Infectious Diseases. 2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>FOPH. COVID-&#x2060;19 Switzerland. Switzerland: Federal Office of Public Health. 2020.</Citation></Reference><Reference><Citation>Ma A, Parry J. When Hong Kong's &#x201c;dynamic zero&#x201d; covid-19 strategy met omicron, low vaccination rates sent deaths soaring. BMJ. 2022;377:o980.</Citation><ArticleIdList><ArticleId IdType="pubmed">35418475</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao J, Cheung JK, Wu P, Ni MY, Cowling BJ, Liao Q. Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys. The Lancet Regional Health - Western Pacific. 2022. 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8961079</ArticleId><ArticleId IdType="pubmed">35359914</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DJ, Hakim AJ, Leung GM, Xu W, Schluter WW, Novak RT. et al. COVID-19 Mortality and Vaccine Coverage - Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022. China CDC Wkly. 2022;4:288&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9008266</ArticleId><ArticleId IdType="pubmed">35433091</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayar E, Abdeen S, Alah MA, Chemaitelly H, Bougmiza I, Ayoub HH, Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar. medRxiv. 2022. 2022. 05.09.22274802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9791790</ArticleId><ArticleId IdType="pubmed">36603377</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghioff SM, Slavin BR, Holton T, Singh D. Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients. Plos One. 2021;16:e0255541&#x2013;e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8330918</ArticleId><ArticleId IdType="pubmed">34343191</ArticleId></ArticleIdList></Reference><Reference><Citation>Junqueira-Kipnis AP, dos Anjos LRB, Barbosa LCdS, da Costa AC, Borges KCM, Cardoso AdRO. et al. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7586662</ArticleId><ArticleId IdType="pubmed">33106170</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenlap S, Piromsopa K, Charoenlap C. Potential role of Bacillus Calmette-Gu&#xe9;rin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects. Asian Pac J Allergy Immunol. 2020;38:150&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">32686943</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar LE, Molina-Cruz A, Barillas-Mury C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19) Proc Natl Acad Sci U S A. 2020;117:17720&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395502</ArticleId><ArticleId IdType="pubmed">32647056</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges KCM, da Costa AC, de Souza Barbosa LC, Ribeiro KM, Dos Anjos LRB, Kipnis A, Tuberculosis, BCG Vaccination and COVID-19: Are They Connected? Mini Rev Med Chem. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">34983348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu W, Ho P-C, Liu C-L, Tzeng K-T, Nayeem N, Moore JS. et al. Reconcile the debate over protective effects of BCG vaccine against COVID-19. Sci Rep-Uk. 2021;11:8356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8052320</ArticleId><ArticleId IdType="pubmed">33863950</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, McHarry K, van den Hoogen G. et al. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022;48:101414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098089</ArticleId><ArticleId IdType="pubmed">35582122</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bree LCJ, Marijnissen RJ, Kel JM, Rosendahl Huber SK, Aaby P, Benn CS. et al. Bacillus Calmette-Gu&#xe9;rin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice. Front Immunol. 2018;9:869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5936970</ArticleId><ArticleId IdType="pubmed">29760700</ArticleId></ArticleIdList></Reference><Reference><Citation>Arts RJW, Moorlag S, Novakovic B, Li Y, Wang SY, Oosting M. et al. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host Microbe. 2018;23:89&#x2013;100.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">29324233</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. Bacille Calmette-Gu&#xe9;rin (BCG) vaccination and COVID-19. 2020.</Citation></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370:423. -+</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Milne A, Maskell S, Sharp C, Hamilton F, Arnold D. Impact of dexamethasone on persistent symptoms of COVID-19: an observational study. medRxiv. 2021. 2021. 11.17.21266392.</Citation></Reference><Reference><Citation>Gallagher-Allred CR, Voss AC, Finn SC, McCamish MA. Malnutrition and clinical outcomes: the case for medical nutrition therapy. J Am Diet Assoc. 1996;96:361&#x2013;6. 9; quiz 7-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8598437</ArticleId></ArticleIdList></Reference><Reference><Citation>Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;46:1582&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18419494</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais AHD, Aquino JD, da Silva-Maia JK, Vale SHD, Maciel BLL, Passos TS. Nutritional status, diet and viral respiratory infections: perspectives for severe acute respiratory syndrome coronavirus 2. Brit J Nutr. 2021;125:851&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7542326</ArticleId><ArticleId IdType="pubmed">32843118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30:367&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186532</ArticleId><ArticleId IdType="pubmed">32346073</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu HR, Tain YL, Tiao MM, Chen CC, Sheen JM, Lin IC, Prenatal dexamethasone and postnatal high-fat diet have a synergistic effect of elevating blood pressure through a distinct programming mechanism of systemic and adipose renin-angiotensin systems. Lipids Health Dis. 2018. 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853160</ArticleId><ArticleId IdType="pubmed">29540174</ArticleId></ArticleIdList></Reference><Reference><Citation>Netea MG, Dominguez-Andres J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E. et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20:375&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186935</ArticleId><ArticleId IdType="pubmed">32132681</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiodini I, Gatti D, Soranna D, Merlotti D, Mingiano C, Fassio A, Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes. Frontiers in Public Health. 2021. 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727532</ArticleId><ArticleId IdType="pubmed">35004568</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P. et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310969</ArticleId><ArticleId IdType="pubmed">28202713</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D. et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. The Lancet Diabetes &amp; Endocrinology. 2021;9:276&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N. et al. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study) Postgraduate Medical Journal. 2022;98:87&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">33184146</ArticleId></ArticleIdList></Reference><Reference><Citation>Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev. 2016;96:365&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839493</ArticleId><ArticleId IdType="pubmed">26681795</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Liu Q, Jiang Y, Yang W, Huang H, Shi C, Surface-displayed porcine IFN-&#x3bb;3 in Lactobacillus plantarum inhibits porcine enteric coronavirus infection of porcine intestinal epithelial cells. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9728374</ArticleId><ArticleId IdType="pubmed">31838830</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud D, Dimopoulou Agri V, Gibson GR, Reid G, Giannoni E. Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic. Frontiers in public health. 2020;8:186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227397</ArticleId><ArticleId IdType="pubmed">32574290</ArticleId></ArticleIdList></Reference><Reference><Citation>Khailova L, Baird CH, Rush AA, Barnes C, Wischmeyer PE. Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia. Clinical Nutrition. 2017;36:1549&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641477</ArticleId><ArticleId IdType="pubmed">27745813</ArticleId></ArticleIdList></Reference><Reference><Citation>Popp M, Stegemann M, Metzendorf MI, Gould S, Kranke P, Meybohm P, Ivermectin for preventing and treating COVID-19. Cochrane Database of Systematic Reviews. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406455</ArticleId><ArticleId IdType="pubmed">34318930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012;42:145&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091063</ArticleId><ArticleId IdType="pubmed">21221847</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Ag. 2020;56:105949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102549</ArticleId><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B, Ryan H, Kredo T, Chaplin M, Fletcher T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Cochrane Database of Systematic Reviews. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094389</ArticleId><ArticleId IdType="pubmed">33624299</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>